Cover Image
市場調查報告書

冠狀動脈導線:醫療設備的開發平台評估

Coronary Guidewires - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 335331
出版日期 內容資訊 英文 100 Pages
訂單完成後即時交付
價格
Back to Top
冠狀動脈導線:醫療設備的開發平台評估 Coronary Guidewires - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年06月06日 內容資訊: 英文 100 Pages
簡介

本報告提供全球冠狀動脈導線市場上,主要開發中產品 (醫療設備)與其臨床實驗的進展調查,產品的功能、特性比較分析 (臨床實驗的各進展階段) ,主要企業簡介及代表性產品,近來的市場動靜 (業績報告、資本交易趨勢等) 資訊彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 冠狀動脈導線概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期

第4章 臨床實驗中的開發中產品:各企業

  • 冠狀動脈導線的企業:各臨床實驗階段的開發中產品
  • 冠狀動脈導線:各臨床實驗階段的開發中產品

第5章 冠狀動脈導線市場:企業、產品概要

  • Bioscan Technologies Inc.
    • 開發中產品及進行中的臨床實驗概要
  • Blueacre Technology Limited
  • Boston Scientific Corp
  • CardioSert Ltd.
  • ENDOMATERIALS
  • Georgia Institute of Technology
  • Guided Interventions, LLC
  • JRjr33, Inc.
  • MaRVis Technologies GmbH
  • MicroPort Scientific Corp
  • Occlutech International AB
  • OVALUM Ltd
  • St. Jude Medical LLC
  • Terumo Corporation
  • The Cleveland Clinic Foundation
  • University of Illinois at Chicago
  • Vasostar Ltd.

第6章 冠狀動脈導線市場:目前的趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's Medical Devices sector report, "Coronary Guidewires - Medical Devices Pipeline Assessment, 2017" provides an overview of Coronary Guidewires currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Guidewires pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Coronary Guidewires under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Coronary Guidewires and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Coronary Guidewires under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Coronary Guidewires Overview

3. Products under Development

  • 3.1. Coronary Guidewires - Pipeline Products by Stage of Development
  • 3.2. Coronary Guidewires - Pipeline Products by Territory
  • 3.3. Coronary Guidewires - Pipeline Products by Regulatory Path
  • 3.4. Coronary Guidewires - Pipeline Products by Estimated Approval Date

4. Coronary Guidewires - Pipeline Products under Development by Companies

  • 4.1. Coronary Guidewires Companies - Pipeline Products by Stage of Development
  • 4.2. Coronary Guidewires - Pipeline Products by Stage of Development

5. Coronary Guidewires Companies and Product Overview

  • 5.1. Bioscan Technologies Inc. Company Overview
    • 5.1.1. Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Blueacre Technology Limited Company Overview
    • 5.2.1. Blueacre Technology Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Boston Scientific Corp Company Overview
    • 5.3.1. Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. CardioSert Ltd. Company Overview
    • 5.4.1. CardioSert Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. ENDOMATERIALS Company Overview
    • 5.5.1. ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Georgia Institute of Technology Company Overview
    • 5.6.1. Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Guided Interventions, LLC Company Overview
    • 5.7.1. Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. JRjr33, Inc. Company Overview
    • 5.8.1. JRjr33, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. MaRVis Technologies GmbH Company Overview
    • 5.9.1. MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. MicroPort Scientific Corp Company Overview
    • 5.10.1. MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Occlutech International AB Company Overview
    • 5.11.1. Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. OVALUM Ltd Company Overview
    • 5.12.1. OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. St. Jude Medical LLC Company Overview
    • 5.13.1. St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Terumo Corp Company Overview
    • 5.14.1. Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. The Cleveland Clinic Foundation Company Overview
    • 5.15.1. The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. University of Illinois at Chicago Company Overview
    • 5.16.1. University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Vasostar Ltd. Company Overview
    • 5.17.1. Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview

6. Coronary Guidewires- Recent Developments

  • 6.1. May 26, 2017: Merit Medical Announces Appointment of New Director
  • 6.2. May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
  • 6.3. Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017
  • 6.4. Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017
  • 6.5. Apr 19, 2017: Abbott Reports First-Quarter 2017 Results
  • 6.6. Apr 19, 2017: Opsens Reports Q2 2017 Results - Quarterly Consolidated Revenues Up 75% to $4.8 Million
  • 6.7. Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board
  • 6.8. Mar 31, 2017: B. Braun continues its sales and earnings growth
  • 6.9. Mar 30, 2017: AngioDynamics Reports Fiscal 2017 Third Quarter Results
  • 6.10. Mar 30, 2017: MPSC Announces 2016 Annual Results
  • 6.11. Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech
  • 6.12. Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia
  • 6.13. Feb 22, 2017: Change in the B. Braun Management Board
  • 6.14. Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
  • 6.15. Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016
  • 6.16. Feb 09, 2017: Terumo Announces Change of Executive Officers
  • 6.17. Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
  • 6.18. Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
  • 6.19. Jan 31, 2017: Terumo Opens a Branch in Yangon
  • 6.20. Jan 26, 2017: Opsens Reports Q1 2017 Results - Focused Execution Leads to Record Quarterly Revenues
  • 6.21. Jan 12, 2017: Anteo Diagnostics Strengthening its Intellectual Property Position in Medical Device Arena
  • 6.22. Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results
  • 6.23. Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy
  • 6.24. Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
  • 6.25. Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
  • 6.26. Nov 16, 2016: Opsens Reports Results for 2016-Record Total Revenues Driven by Tenfold Increase in FFR Sales
  • 6.27. Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
  • 6.28. Nov 09, 2016: AngioDynamics Announces Addition of New Board Members
  • 6.29. Nov 03, 2016: DSM Q3 2016 Results
  • 6.30. Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016
  • 6.31. Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016
  • 6.32. Oct 24, 2016: St. Jude Medical Announces Data to be Presented as Late-Breaking Clinical Trials and Highlights Its Latest Cardiovascular Portfolio at the 2016 TCT Conference
  • 6.33. Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results
  • 6.34. Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results
  • 6.35. Oct 12, 2016: Hydromer Announces Entering Into 2 Coating Service Agreements Leveraging Its Medical Device Subsidiary, Biosearch Medical Products
  • 6.36. Oct 10, 2016: St. Jude Medical Announces FDA Clearance and Launch of the New PressureWire X Guidewire Designed to Optimize PCI Procedures in Patients With Complex Anatomies
  • 6.37. Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
  • 6.38. Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results
  • 6.39. Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
  • 6.40. Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China
  • 6.41. Aug 30, 2016: MPSC Announces 2016 Interim Results
  • 6.42. Aug 25, 2016: Medtronic Reports First Quarter Financial Results
  • 6.43. Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016
  • 6.44. Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016
  • 6.45. Jul 26, 2016: Merit Medical Announces Appointment of New Director
  • 6.46. Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer
  • 6.47. Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results
  • 6.48. Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results
  • 6.49. Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors
  • 6.50. Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results
  • 6.51. Jul 05, 2016: Opsens Announces Fiscal 2016 Third Quarter Results - Sales Of $2,125,000, Up 156% Year-Over-Year
  • 6.52. Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
  • 6.53. Jun 22, 2016: Opsens receives Health Canada approval for the sale of OptoWire II

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Coronary Guidewires - Pipeline Products by Stage of Development
  • Table 2: Coronary Guidewires - Pipeline Products by Territory
  • Table 3: Coronary Guidewires - Pipeline Products by Regulatory Path
  • Table 4: Coronary Guidewires - Pipeline Products by Estimated Approval Date
  • Table 5: Coronary Guidewires Companies - Pipeline Products by Stage of Development
  • Table 6: Coronary Guidewires - Pipeline Products by Stage of Development
  • Table 7: Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: Lightwire - Product Status
  • Table 9: Lightwire - Product Description
  • Table 10: Blueacre Technology Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 11: Next Generation Guide Wire - Product Status
  • Table 12: Next Generation Guide Wire - Product Description
  • Table 13: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: Crossing Wire - Product Status
  • Table 15: Crossing Wire - Product Description
  • Table 16: CardioSert Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Versatile Guidewire - Product Status
  • Table 18: Versatile Guidewire - Product Description
  • Table 19: ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Multimodal Sensing Guidewire - Product Status
  • Table 21: Multimodal Sensing Guidewire - Product Description
  • Table 22: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Intravascular Ultrasound Imaging Guidewire - Product Status
  • Table 24: Intravascular Ultrasound Imaging Guidewire - Product Description
  • Table 25: Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Pressure Sensing Coronary Artery Guide Wire - Product Status
  • Table 27: Pressure Sensing Coronary Artery Guide Wire - Product Description
  • Table 28: JRjr33, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Maneuverable Coiled Guidewire - Product Status
  • Table 30: Maneuverable Coiled Guidewire - Product Description
  • Table 31: Steerable Guidewire - Product Status
  • Table 32: Steerable Guidewire - Product Description
  • Table 33: MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: MaRVis 0.014" Micro Guidewire - Product Status
  • Table 35: MaRVis 0.014" Micro Guidewire - Product Description
  • Table 36: MaRVis 0.035" Standard And Stiff Guidewire - Product Status
  • Table 37: MaRVis 0.035" Standard And Stiff Guidewire - Product Description
  • Table 38: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Micro-Guide Wire - Product Status
  • Table 40: Micro-Guide Wire - Product Description
  • Table 41: Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Occlutech Stiff Guide Wire - Product Status
  • Table 43: Occlutech Stiff Guide Wire - Product Description
  • Table 44: OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: OctoBooster Extension Guidewire - Product Status
  • Table 46: OctoBooster Extension Guidewire - Product Description
  • Table 47: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Sensor Enabled - Quadra Excel Guidewire - Product Status
  • Table 49: Sensor Enabled - Quadra Excel Guidewire - Product Description
  • Table 50: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Wrist Artery Guidewire - Product Status
  • Table 52: Wrist Artery Guidewire - Product Description
  • Table 53: The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: CTO Guidewire - Product Status
  • Table 55: CTO Guidewire - Product Description
  • Table 56: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: CTO Wire - Product Status
  • Table 58: CTO Wire - Product Description
  • Table 59: Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Vibrational Guidewire System - Product Status
  • Table 61: Vibrational Guidewire System - Product Description
  • Table 62: Glossary

List of Figures

  • Figure 1: Coronary Guidewires - Pipeline Products by Stage of Development
  • Figure 2: Coronary Guidewires - Pipeline Products by Territory
  • Figure 3: Coronary Guidewires - Pipeline Products by Regulatory Path
  • Figure 4: Coronary Guidewires - Pipeline Products by Estimated Approval Date
Back to Top